Results 231 to 240 of about 50,171 (265)

Multilayer surface coating for enhanced anti-inflammation, anti-restenosis, and re-endothelialization in advanced biodegradable vascular stents. [PDF]

Mater Today Bio
Song DH, Baik S, Kim JY, Park JM, Ryu B, Seo IH, Lee SS, Kim HB, Hong YJ, Koh WG, Ryu W, Kim YC, Lee DR, Han DK.   +13 more
europepmc   +1 more source

A computational model of coronary arteries with in-stent restenosis coupling hemodynamics and pharmacokinetics with growth mechanics. [PDF]

Sci Rep
Ranno A, Manjunatha K, Koritzius T, Steinbrecher I, Hosters N, Nachtsheim M, Nilcham P, Schaaps N, Turoni-Glitz A, Datz J, Popp A, Linka K, Vogt F, Behr M.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Restenosis following coronary angioplasty

The International Journal of Cardiac Imaging, 1990
The assessment of restenosis following angioplasty has become increasingly important in determining the clinical value of the procedure. Despite this there has been no uniformly accepted methodology for assessing the procedure and consequently the published results have often been misleading with little concensus.
K J, Beatt, P W, Serruys
openaire   +4 more sources

Coronary Restenosis

Journal of the American Academy of Nurse Practitioners, 1996
Return of angina within 6 months of a catheter-based treatment of coronary artery disease usually reflects restenosis due to an overly aggressive local healing response to the procedure-related arterial injury. The restenotic lesion should be treated aggressively.
C, Brown, L, Clark, L, Williams, S, Gallagher, M, Levesque, J, Silva   +5 more
openaire   +2 more sources

Prevention of Coronary Restenosis

Cardiology in Review, 1999
Percutaneous transluminal coronary angioplasty (PTCA) was introduced 22 years ago as a nonsurgical catheter-based treatment for obstructive coronary artery disease. Over the following 2 decades, major advances in equipment and techniques led to tremendous growth in the use of PTCA to treat coronary artery disease and angina.
P J, Casterella, P S, Teirstein
openaire   +2 more sources

Costs of coronary restenosis (Lovastatin Restenosis Trial)

The American Journal of Cardiology, 1996
Within the Lovastatin Restenosis Trial, restenosis has been clearly shown to increase resource utilization and costs. While it is not possible to generalize these results to other patient populations, it is clear that successful efforts to decrease restenosis will certainly improve efficacy while decreasing follow-up costs and increasing the cost ...
S P, Gilbert, W S, Weintraub, J D, Talley, S J, Boccuzzi   +3 more
openaire   +2 more sources

Coronary dissection: A predictor of restenosis?

American Heart Journal, 1988
To determine if arterial dissection resulting from transluminal coronary angioplasty (TCA) leads to a greater incidence of restenosis, 273 consecutive patients who had undergone TCA with at least 1 year of follow-up were examined. Success was graded as a greater than or equal to 20% increase in intraluminal diameter.
B J, Matthews, C J, Ewels, K M, Kent
openaire   +2 more sources

Coronary In-Stent Restenosis: Assessment with CT Coronary Angiography

Radiology, 2012
To compare accuracy and radiation exposure of a new computed tomographic (CT) scanner with improved spatial resolution (scanner A) with those of a CT scanner with standard spatial resolution (scanner B) for evaluation of coronary in-stent restenosis (ISR) by using invasive coronary angiography (ICA) and intravascular ultrasonography (US) as reference ...
D. Andreini, G. Pontone, S. Mushtaq, A.L. Bartorelli, E. Bertella, D. Trabattoni, P. Montorsi, S. Galli, C. Foti, A. Annoni, F. Bovis, G. Ballerini, P. Agostoni, C. Fiorentini, M. Pepi   +14 more
openaire   +2 more sources

Coronary Brachytherapy and Restenosis

Heart Drug, 2001
The antiproliferative effects of radiotherapy have been used clinically for over 100 years to treat several benign disorders. More recently, several experimental studies have convincingly demonstrated that the use of intracoronary radiotherapy results in marked modulation of the restenotic process.
Donald Latchem, Philip Urban
openaire   +1 more source

[Coronary restenosis].

Herz, 2019
Coronary restenosis is the answer of the arterial wall to a mechanical violation through balloon angioplasty, bare-metal (BM) stent implantation or rotational atherectomy through repeated narrowing. It has great clinical and prognostic relevance and occurs in approximately 30% of non-coated stents and in 10% of coated coronary stents. The wound healing
R J, Zotz, U, Dietz, S, Lindemann, S, Genth-Zotz   +3 more
openaire   +1 more source